Latest News

MPE at ASH 2024: key research and expert insights on myeloma

At the 2024 American Society of Hematology (ASH) Annual Meeting, Myeloma Patients Europe (MPE) interviewed experts about the most interesting studies and abstracts in myeloma and AL amyloidosis research that were presented during the conference. Our series of interviews highlights key findings and their impact on patient care: 🎥 Dr. Laurent Garderet discusses the IFM2017-03…

Read more

Myeloma and AL amyloidosis ASH 2024 preview

The American Society of Hematology (ASH) Annual Meeting, the world’s largest haematology conference, will take place from 7 – 10 December in San Diego, United States. It is a very exciting event for the myeloma and AL amyloidosis clinical and patient community, with all the results from the latest and most important research being presented.…

Read more

Watch the recording of webinar “AL amyloidosis treatment updates and patient experiences”

Myeloma Patients Europe (MPE) held a webinar to summarise the most important AL amyloidosis updates and share patient experiences with therapies like CAR-T and CAEL-101. The webinar took place on 16th April 2024 and was given by Dr. Moshe Gatt, Physician Researcher Haematologist at the Hebrew University of Jerusalem, Israel, along with two AL Amyloidosis patients from Israel, Naphtali Mastboim…

Read more

MPE launches the Myeloma and AL Amyloidosis European Clinical Trial Navigator

Brussels, 23 April 2024 – Myeloma Patients Europe (MPE) has launched today the English version of the Myeloma and AL Amyloidosis European Clinical Trial Navigator, an online search tool to learn about and find clinical trials for myeloma, monoclonal gammopathy of undetermined significance (MGUS), smouldering multiple myeloma (SMM) and AL amyloidosis in Europe. With this tool, MPE wants to facilitate the search…

Read more

Sign up for the MPE webinar “AL amyloidosis treatment updates and patient experiences on new therapies”

Myeloma Patients Europe (MPE) will hold the webinar “AL amyloidosis treatment updates and patient experiences on new therapies” on Tuesday 16 April from 17:00 – 18:00 CEST. The webinar will be given by Dr. Moshe Gatt, Physician Researcher Haematologist at the Hebrew University of Jerusalem, Israel, along with two AL Amyloidosis patients from Israel, Naphtali Mastboim and Melvin Granatstein, who…

Read more

ASH 2023 | Myeloma and AL amyloidosis updates

Myeloma Patients Europe (MPE) attended the 65th American Society of Hematology (ASH) Annual Meeting, the largest haematology congress, held from 9 to 12 December in San Diego (United States). MPE has interviewed haematology experts to summarise the latest myeloma and AL amyloidosis updates.   Prof. Dr. Michel Delforge, Department of Haematology, University Hospital Leuven, Belgium, explains…

Read more

November 2026

MO
TU
WE
TH
FR
SA
SU
26
27
28
29
30
31
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
1
2
3
4
5
6
Events for 1st November
No Events
Events for 2nd November
No Events
Events for 3rd November
No Events
Events for 4th November
No Events
Events for 5th November
No Events
Events for 6th November
No Events
Events for 7th November
No Events
Events for 8th November
No Events
Events for 9th November
No Events
Events for 10th November
No Events
Events for 11th November
No Events
Events for 12th November
No Events
Events for 13th November
No Events
Events for 14th November
No Events
Events for 15th November
No Events
Events for 16th November
No Events
Events for 17th November
No Events
Events for 18th November
No Events
Events for 19th November
No Events
Events for 20th November
No Events
Events for 21st November
No Events
Events for 22nd November
No Events
Events for 23rd November
No Events
Events for 24th November
No Events
Events for 25th November
No Events
Events for 26th November
No Events
Events for 27th November
No Events
Events for 28th November
No Events
Events for 29th November
No Events
Events for 30th November
No Events